OLETA SCHRANZ: Open Payments
NPI 1598020521 · CELINA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 33 payments from 10 companies in 2025. Trend: 2023 $562 · 2024 $566 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 15 | $366 |
| Axsome Therapeutics, Inc. | 4 | $64 |
| PFIZER INC. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Korlym, Auvelity, NURTEC ODT, REXULTI, OTEZLA, MOUNJARO, VRAYLAR, SPRAVATO.
Industry payments across TX — which companies pay providers there.
